Detroit R&D Receives $850K from NIH to Develop Recombinant Antibodies, Antibody Array | GenomeWeb

NEW YORK, Oct. 7 (GenomeWeb News) - Detroit R&D recently received a $100,000 Phase I Small Business Innovation Research award from the National Institutes of Health to fund the production of single-chain recombinant antibodies for early detection of cancer.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.